Research map: Concentration-dependent suppression of macrolide resistance in Mycobacterium avium by combination therapy: An improved in vitro time-kill assay and alveolar macrophage exposure-based pharmacokinetic/pharmacodynamic modeling study

Back to the article

Papers in this map

  1. Ways to Fit a PK Model with Some Data Below the Quantification Limit · Stuart L. Beal · 2001 · 1123 citations · Cited by this paper
  2. Antimicrobial susceptibility and resistance gene profiles of Prevotella spp. isolated in Oita University Hospital, Japan · 2026 · Related
  3. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline · Charles L. Daley · 2020 · 946 citations · Cited by this paper
  4. A case report of tetanus complicated by multiple cerebral infarcts and iliopsoas hematoma · 2026 · Related
  5. Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease · David E. Griffith · 2006 · 359 citations · Cited by this paper
  6. Impact of the antimicrobial stewardship incentive program on antimicrobial supply instability: An interrupted time-series analysis using national drug supply data · 2026 · Related
  7. Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid · Sungmin Kiem · 2007 · 292 citations · Cited by this paper
  8. Mycoplasma genitalium infection and pelvic inflammatory disease: A 12-month prospective study in Japanese women · 2026 · Related
  9. Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid · Keith A. Rodvold · 2011 · 247 citations · Cited by this paper
  10. Rhino-orbito-cerebral fungal infection associated with mixed Cladosporium halotolerans and Penicillium corylophilum, complicated by internal carotid artery occlusion and ischemic stroke: a case report · 2026 · Related
  11. The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment · Jakko van Ingen · 2012 · 205 citations · Cited by this paper
  12. Legionnaire's disease with limbic encephalitis · 2026 · Related
  13. The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance · Aurelia Schmalstieg · 2012 · 203 citations · Cited by this paper
  14. Effectiveness of oral beta-lactam antibiotics in acute bacterial prostatitis: A retrospective study · 2026 · Related
  15. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers · Keith A. Rodvold · 1997 · 200 citations · Cited by this paper
  16. Sepsis-like symptoms from parechovirus A type 5 in a neonate: First Japanese case and literature review · 2026 · Related
  17. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease · Yoshihiro Kobashi · 2006 · 163 citations · Cited by this paper
  18. Impact of the “DPC Special Provision” on COVID-19 inpatient case identification in Japanese administrative databases · 2026 · Related
  19. Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases · Kozo Morimoto · 2016 · 156 citations · Cited by this paper
  20. Human bacteraemia caused by Pseudomonas plecoglossicida, a fish pathogen of ayu (Plecoglossus altivelis): a case report · 2026 · Related
  21. The Role of PK/PD Parameters to Avoid Selection and Increase of Resistance: Mutant Prevention Concentration · Joseph M. Blondeau · 2004 · 156 citations · Cited by this paper
  22. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin · Julie M. Jarand · 2015 · 146 citations · Cited by this paper
  23. Mycobacterium tuberculosis-macrophage interaction: Molecular updates · Haotian Bo · 2023 · 141 citations · Cited by this paper
  24. Steady-State Intrapulmonary Concentrations of Moxifloxacin, Levofloxacin, and Azithromycin in Older Adults · Blair Capitano · 2004 · 119 citations · Cited by this paper
  25. A Tutorial on RxODE: Simulating Differential Equation Pharmacometric Models in R · W Wang · 2015 · 109 citations · Cited by this paper
  26. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses · K M Olsen · 1996 · 105 citations · Cited by this paper
  27. Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution · Gabrielle Fröberg · 2023 · 61 citations · Cited by this paper
  28. Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex · C. Truffot-Pernot · 1991 · 56 citations · Cited by this paper
  29. Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease · Joong‐Yub Kim · 2022 · 41 citations · Cited by this paper
  30. Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment · Sanne M.H. Zweijpfenning · 2023 · 39 citations · Cited by this paper
  31. In Vitro MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease · Byoung Soo Kwon · 2018 · 36 citations · Cited by this paper
  32. Inhaled Antibiotics for Mycobacterial Lung Disease · Brandon J. H. Banaschewski · 2019 · 35 citations · Cited by this paper
  33. Antimycobacterial Agents Differ with Respect to Their Bacteriostatic versus Bactericidal Activities in Relation to Time of Exposure, Mycobacterial Growth Phase, and Their Use in Combination · Irma A. J. M. Bakker‐Woudenberg · 2005 · 34 citations · Cited by this paper
  34. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease · Jinsoo Min · 2015 · 29 citations · Cited by this paper
  35. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy · Yasuhiro Ito · 2020 · 25 citations · Cited by this paper
  36. Drug resistance reversal potential of multifunctional thieno[3,2-c]pyran via potentiation of antibiotics in MDR P. aeruginosa · Gaurav Raj Dwivedi · 2021 · 21 citations · Cited by this paper
  37. Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis · Andrew D. McCallum · 2020 · 20 citations · Cited by this paper
  38. Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics · Eunjeong Shin · 2024 · 15 citations · Cited by this paper
  39. Amikacin pharmacokinetics in elderly patients with severe infections · Susanna Edith Medellín‐Garibay · 2022 · 14 citations · Cited by this paper

Source: OpenAlex (CC0)